**SALE        AND PURCHASE AGREEMENT**

**BETWEEN**

**MED-EQ        AS**

**AND**

**AMERIKAL        NUTRACEUTICAL CORP**

----

**CONTENTS**

| **ART.                    1**             | **DEFINITIONS                    AS USED IN THIS AGREEMENT**        | **3**  |
|-------------------------------------------|---------------------------------------------------------------------|--------|
|                                      |                                                                |   |
| **ART.                    2**             | **ISSUING                    OF PURCHASE NOTICE**                   | **4**  |
|                                      |                                                                |   |
| **ART.                    3**             | **SALE                    AND PURCHASE OF PRODUCTS**                | **4**  |
|                                      |                                                                |   |
| **ART.                    4**             | **LEGAL                    SITUATION OF AMERIKAL**                  | **5**  |
|                                      |                                                                |   |
| **ART.                    5**             | **TRADEMARK,                    PROPRIETARY RIGHTS, AND PACKAGING** | **5**  |
|                                      |                                                                |   |
| **ART.                    6**             | **COMPETING                    PRODUCTS**                           | **6**  |
|                                      |                                                                |   |
| **ART.                    7**             | **MINIMUM                    PURCHASES**                            | **6**  |
|                                      |                                                                |   |
| **ART.                    8**             | **MED-EQ'S                    PRICES AND TERMS OF SALE**            | **6**  |
|                                      |                                                                |   |
| **ART.                    9**             | **PRODUCT                    LIABILITY**                            | **7**  |
|                                      |                                                                |   |
| **ART.                    10**            | **SECRECY**                                                         | **7**  |
|                                      |                                                                |   |
| **ART.                    11**            | **FORCE                    MAJEURE**                                | **8**  |
|                                      |                                                                |   |
| **ART.                    12**            | **TERM                    OF THIS AGREEMENT AND TERMINATION**       | **8**  |
|                                      |                                                                |   |
| **ART.                    13**            | **EARLY                    TERMINATION**                            | **9**  |
|                                      |                                                                |   |
| **ART.                    14**            | **INDEMNITY                    AND COMPENSATION**                   | **9**  |
|                                      |                                                                |   |
| **ART.                    15**            | **GOVERNING                    LAW AND ARBITRATION**                | **9**  |
|                                      |                                                                |   |
| **ART.                    16**            | **ASSIGNABILITY**                                                   | **10** |
|                                      |                                                                |   |
| **ART.                    17**            | **PLEDGE                    OR LIEN**                               | **11** |
|                                      |                                                                |   |
| **ART.                    18**            | **NOTICES**                                                         | **11** |
|                                      |                                                                |   |
| **LIST                    OF APPENDIXES** | **12**                                                              |

----

**WITNESSETH**

| Whereas | Med-Eq                  has developed and causes to be manufactured certain raw materials                  and                  pre-mixes (hereinafter referred to as the "Product") as described                  in                  Appendix                  1                  attached hereto; |
|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| Whereas | the                  Amerikal is engaged in the business of manufacturing, marketing,                  sales and                  distribution of certain dietary supplements and related products;                  and |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| Whereas | Amerikal                  is desirous of purchasing the Product for use in its own formulations                  as                  an aphrodiziac and/or in sports products, and Med-Eq                  is desirous of supplying the Product to Amerikal for this purpose                  in the                  Territory (as hereinafter defined) |
|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| **Art.                  1** | **Definitions                  as used in this Agreement** |
|-----------------------------|------------------------------------------------------------|

| 1.1 | The                  "Product" as used in this Agreement shall mean the Product described                  in                  Appendix 1, developed by and manufactured under the control of                  Med-Eq and                  such other products as agreed in writing from time to time between                  the                  Parties and as amended in Appendix                  1.                  The “Product” shall mean both the finnished product formulations as well                  as pre-mixes and other less confectioned forms. |
|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 1.2 | "Territory"                  as used in this Agreement shall mean the Whole                  World |
|-----|----------------------------------------------------------------------------------------------------|

| 1.3 | "Trademark"                  shall mean the trademark, design and get-up described in Appendix                  3                  hereof. |
|-----|--------------------------------------------------------------------------------------------------------------------------------------------|

| 1.4 | "Working                  Week" as used in this Agreement shall mean five (5) days under                  Norwegian                  law, whether consecutive or                  otherwise. |
|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 1.5 | "Information"                  as used in this Agreement shall mean any identified business or                  trade                  secret of the other party such as - but not limited to - documentation                  ,                  information concerning the Product and quality control obtained                  in written                  or verbal form. |
|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 1.6 | "Affiliate"                  in relation to either Party means any corporation which Controls                  or is                  Controlled by that Party. |
|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 1.7 | “Agreement”                  means this Sale and Purchase Agreement and any and all Schedules                  hereto as                  may be amended, modified or supplemented from time to time in accordance                  with the terms hereof. |
|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| 1.8 | “Approved                  Purchase Notice” shall have the meaning ascribed thereto in Clause                  3.1. |
|-----|---------------------------------------------------------------------------------------------------------------------------------|

| 1.10 | “Purchase                  Notice” shall have the meaning ascribed thereto in Clause                  2.1 |
|------|-----------------------------------------------------------------------------------------------------------------------|

| 1.11 | “Term”                  means the period commencing from the Commencement Date and ending                  upon its                  termination in accordance with this Agreement. |
|------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| **Art.                  2** | **Issuing                  of Purchase Notice** |
|-----------------------------|-------------------------------------------------|

| 2.1 | Amerikal                  may from time to time during the Term request Med-Eq to manufacture,                  sell                  and deliver to the Amerikal such Products and in such quantities                  thereof                  as the Amerikal may require by giving written notice thereof to                  the                  Med-Eq. Each such notice served on Amerikal (the “Purchase Notice”) shall                  state: |
|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 2.2 | Each                  Purchase Notice shall constitute a separate order to Med-Eq. Med-Eq                  shall                  use its best efforts to accept each Purchase Notice, and shall                  forthwith                  Amerikal of the Purchase Notice in writing if Med-Eq is for any                  reason                  unable to fulfil the requirements of the Purchase Notice. If Med-Eq                  fails                  to give such notice to Amerikal within seven (7) days of the date                  of                  issuance of the Purchase Notice, Med-Eq shall be deemed to have                  accepted                  the Purchase Notice in its                  entirety. |
|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 2.3 | Effective                  from the end of the first 6 months period after signing of this                  Agreement,                  Amerikal shall, in order to secure Med-Eq's production planning,                  prepare a                  revolving purchase budget for six (6) months, such purchase budget                  to                  updated once every month. |
|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| **Art.                  3** | **Sale                  and Purchase of Products** |
|-----------------------------|----------------------------------------------------|

| 3.1 | In                  the event that Med-Eq accepts or is deemed to accept any Purchase                  Notice                  (the “Approved Purchase Notice”), Med-Eq shall sell, and Amerikal shall                  purchase, the Products to which such Approved Purchase Notice relates                  subject to the terms of this Agreement.  |
|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 3.2 | Unless                  otherwise agreed by the Parties in writing, in relation to any                  Approved                  Purchase Notice, Med-Eq shall: |
|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 3.2.1 | provide                  Amerikal with full details of the location at which Med-Eq will                  effect                  delivery pursuant to such Approved Purchase Notice at least seven                  (7) days                  prior to each delivery date stated in such Approved Purchase Notice;                  and |
|--------|-------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 3.2.2 | manufacture                  and sell to Amerikal the Products stated in any Approved Purchase                  Notice                  and in the quantities stated in the Approved Purchase Notice and                  deliver                  them to Amerikal at the location referred to in Clause 3.2.1 by                  the date                  or dates stated in the Approved Purchase Notice.  |
|--------|-------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 3.3 | Risk                  relating to the Products relating to an Approved Purchase Notice                  shall                  pass from Med-Eq                  and vest in Amerikal when custody and control of the Products are                  delivered                  to Amerikal (or to such other person as may be authorised or designated                  by                  Amerikal). |
|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 3.4 | Med-Eq                  represents and warrants to Amerikal that each Product sold by Med-eq                  under                  this Agreement is of satisfactory quality and is reasonably fit                  for the                  purposes for which such Product is ordinarily required or used.                  Med-Eq is                  able to pass clean and marketable title to such Product in accordance                  with                  the terms of this Agreement. |
|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| **Art.                4** | **Legal                  Situation of Amerikal** |
|---------------------------|--------------------------------------------------|

| 4.1 | Amerikal                  shall buy and sell in his own name and for his own account. He                  shall act                  as independent trader towards both Med-Eq as well as the customers.                  He                  shall effectively promote the sale of the Product in the Territory,                  without being authorized to act in the name of Med-Eq. Furthermore,                  he                  shall safeguard the interests of Med-Eq with the due diligence                  of a                  responsible businessman and shall always keep Med-Eq informed of                  his                  activities as well as of the market conditions within the                  Territory. |
|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| **Art.                5** | **Trademark,                  Proprietary Rights, and                  Packaging** |
|---------------------------|------------------------------------------------------------------------------------|

| 5.1 | All                  Trademarks, Documentation and Proprietary Rights relating to the                  Product                  is the sole property of Med-Eq, and Amerikal the cooperation under                  this                  Agreement shall not give Amerikal any share in such rights. |
|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 5.2 | Med-Eq                  authorises hereby Amerikal under the Term of this Agreement to                  use the                  Product in its own formulations, to be sold under its own trademark,                  for                  all purposes other than as an anti-depressant or against                  dementia. |
|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 5.3 | Med-Eq                  authorises hereby Amerikal to refer to documentation performed                  by Med-Eq                  for the Product or for formulations containing the Product, but                  shall in                  the case of such references are made, ensure that Med-Eq in no                  way shall                  be liable for Amerikal’s or its customers’ product claims |
|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 5.4 | Amerikal                  warrants that all packaging materials and all marketing material                  to be                  used for products containing the Product shall bear the text “Contains                  YTE®. A registered trademark owned by Med-Eq AS,                  Norway.” |
|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 5.5 | Amerikal                  undertakes to accept any changes in the production process, the                  specification, that Med-Eq at its sole discretion may decide in                  order to                  improve the quality of the Product or in order to meet changes                  in                  legislation or customer demand. |
|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 5.6 | Amerikal                  is not without Med-Eq's prior written consent in any way - electronically                  on the Internet or otherwise - entitled to register any of Med-Eq's                  intellectual proprietary rights such as - but not limited to -                  trademarks,                  product names, descriptions etc. |
|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| **Art.                  6** | **Competing                  Products** |
|-----------------------------|-----------------------------------------|

| 6.1 | The                  Distributor shall not during the term of this Agreement and for                  a period                  of five (5) years after the expiry of this agreement for whatever                  reason                  manufacture, cause to be manufactured, market, sell, distribute,                  represent, or otherwise deal or have any interest in any goods                  in the                  Territory that are identical,                  or if said goods fulfils identical purposes and contains extract                  from                  eggs, without first obtaining Med-Eq's written consent. Med-Eq                  shall                  respond to any such written request for permission within ninety                  (90) days                  of receipt of the request. |
|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| **Art.                  7** | **Minimum                  Pur-chases** |
|-----------------------------|-----------------------------------------|

| 7.1 | Minimum                  purchases by the Distributor the first five (5) calendar years                  of this                  Agreement of the Product shall be as stated in Appendix                  1.                  Thereafter, minimum purchases shall be agreed upon not later than                  15th                  of                  September of each calendar year, the first such agreement to be                  reached                  not later than 15th                  of                  September, 2010. |
|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| **Art.****8** | **Med-Eq's                  Prices and Terms of Sale** |
|---------------|--------------------------------------------------------|

| 8.1 | Med-Eq's                  sales price for the Product shall be as stated in Appendix                  1                  attached hereto until further notice. During the term of this Agreement,                  the prices for orders not yet confirmed by Med-Eq may be changed                  by Med-Eq                  subject to three (3) month's prior notice in                  writing. |
|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 8.2 | Invoicing                  and payments for the Product shall take place in NOK for any given                  Product. |
|-----|-------------------------------------------------------------------------------------------------------------------------|

| 8.3 | The                  conditions of payment shall Irrevocable L/C or other payment methods                  acceptable by both parties. |
|-----|----------------------------------------------------------------------------------------------------------------------------------------|

| 8.4 | The                  delivery terms of the Product shall be " CPT LAX (Los Angeles)                  Inco-terms                  2000". |
|-----|-----------------------------------------------------------------------------------------------------------------------------------------|

| 8.5 | Med-Eq                  shall prepare all export documentation, supply, package and ship                  the                  Product. Title to the Products shall pass to the Distributor when                  full                  payment for each consignment has taken                  place. |
|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 8.6 | Amerikal                  shall store the Product strictly in accordance with the instructions                  given                  by Med-Eq, see Appendix                  1. |
|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 8.7 | Amerikal                  shall inspect the Product for defects promptly upon receipt thereof.                  Products which are not rejected in writing within fourteen (14)                  days of                  receipt by Amerikal shall be deemed to be in good condition on                  receipt. |
|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | Med-Eq                  shall substitute at its own expense such defective Products by                  delivery of                  Products free from defects. This replacement constitutes the only                  liability of Med-Eq in relation to defective Products, see, however,                  Article 9 below concerning injury to third parties caused by defects                  in                  the Product. |
|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 8.8 | In                  case of delay beyond Med-Eq ́s control or in case of defects Med-Eq is not                  liable for loss of production, loss of profit or any other consequential                  economic loss. |
|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| **Art.****9** | **Product                  Liability** |
|---------------|----------------------------------------|

| 9.1 | Med-Eq                  shall indemnify and hold the Distributor harmless from losses or                  injuries                  suffered by third parties caused by defects in the Product. Med-Eq                  shall                  not be liable for loss of production, loss of profit or any other                  consequential economic loss. |
|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 9.2 | Amerikal                  shall indemnify and hold Med-Eq harmless against any claims including                  product liability claims relating to Amerikal’s confectioning of the                  finished Products, application, administra-tion, packaging, use,                  storage,                  promotion, marketing, resale and distribution of the Product and                  from any                  claims concerning loss of production, loss of profit or any other                  consequential economic loss. |
|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| **Art.****10** | **Secrecy** |
|----------------|-------------|

| 10.1 | Amerikal                  untertakes to treat received Information as strictly confidential                  and                  therefore not to disclose it to any third party (except reliable                  employees                  under secrecy obligation), and to make no commercial use of it                  without the                  express consent of Med-Eq. This obligation applies to Information                  disclosed to Amerikal prior to entering into this Agreement as                  well as                  Information disclosed to Amerikal under this Agreement. In case                  Information is received in oral form the above obligation shall                  only apply                  to the extent such oral Information has been confirmed in writing                  to                  Amerikal and marked "Confiden-tial" within forty-five (45) days                  after the                  date of oral disclosure. |
|------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 10.2 | Amerikal                  agrees to protect the Information from disclosure to any unauthorized                  party. |
|------|-------------------------------------------------------------------------------------------------------------------------|

|   | This                  obligation shall not apply to: |
|--------|------------------------------------------------------|

|  | a) | Information                  which, at the time of disclosure, is already in the public domain; |
|--|----|-------------------------------------------------------------------------------------------------|

|   | b) | Information                  which, after disclosure, becomes a part of the public domain by                  publication through no violation of this                  Agreement; |
|--------|----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | c) | Information                  which Amrikal is able to prove to be in possession of prior to                  any                  disclosure. In this case, Amerikal will demonstrate that he is                  in                  possession of this Information in writing within thirty (30) days                  of                  receipt of Information, or forego application of this                  provision; |
|--------|----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | d) | Information                  which is hereafter lawfully disclosed by a third party to Amerikal,                  where                  third party did not acquire the Information under a still effective                  obligation of confidentiality to                  Med-Eq. |
|--------|----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 10.3 | Nothing                  in this article shall be construed as granting to Amerikal, by                  implication                  or otherwise, any license with respect to the Information or any                  patent                  applications, patents or any claims of patent now or hereafter                  filed or                  issued with respect to the                  Information. |
|------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| **Art.                  1****1** | **Force                  Majeure** |
|----------------------------------|------------------------------------|

| 11.1 | The                  following circumstances shall be considered as grounds for relief                  if they                  impede the performance of the Agreement or makes performance unreasonably                  onerous: industrial disputes and any other circumstance beyond                  the control                  of the parties such as fire, war, mobilization or military call                  up of a                  comparable scope, requisition, seizure, currency restrictions,                  insurrection and civil commotion, shortage of transport, general                  shortage                  of materials, restrictions in use of power and defects or delays                  in                  deliveries by sub-contractors caused by any such circumstance as                  referred                  to in this article. |
|------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | The                  above described circumstances shall constitute grounds for relief                  only if                  their effect on the performance of the Agreement or the delivery                  of a                  specific consignment of the Product could not be foreseen at the                  time of                  formation of the Agreement or the time of delivery of a specific                  consignment of the Product. |
|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|   | The                  party wishing to claim relief shall notify the other party in writing                  without delay on the intervention and on the cessation of such                  circumstance. |
|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | If                  grounds for relief prevent Amerikal from fulfilling his obligations,                  he                  shall compensate Med-Eq for expenses incurred in securing and protecting                  the Product. |
|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 11.2 | In                  the event that the Force Majeure events as defined in Article 13.1                  last                  longer than six (6) months either party is entitled to terminate                  this                  Agreement with one month's prior written notice, such termination                  to be                  effective at the end of any month corresponding to the expiry month                  of                  said notice period. |
|------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| **Art.                  1****2** | **Term                  of this Agreement and                  Termination** |
|----------------------------------|------------------------------------------------------------------------------|

| 12.1 | This                  Agreement shall take effect on __________, 2005 and shall remain                  in force                  until 31st                  of                  December 2010. Hereafter the Agreement shall remain in force for                  consecutive terms of twelve (12) months at a time unless terminated                  by one                  of the parties with a prior written notice of three (3) months                  which at                  the earliest can be given on the 30th                  of                  September 2010 for expiry the 31st                  of                  December 2010. |
|------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 12.2 | Any                  termination of this Agreement as provided herein shall not relieve                  either                  party of any obligation arising hereunder prior to such termination,                  including, but not limited to, Amerikal’s obligation to |
|------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (a) | purchase                  Product covered by purchase orders submitted by Amerikal; |
|--------|-----|-------------------------------------------------------------------------------------|

|   | (b) | pay                  to Med-Eq the cost of any raw materials, including packaging, purchased                  by                  Med-Eq in contemplation of purchase orders to be received in accordance                  with Appendix                  4,                  or Med-Eq's obligation to ship products on accepted                  orders. |
|--------|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 12.3 | If                  Med-Eq, for whatever reason, should deem it necessary to cease                  production                  of the Product, Med-Eq shall be entitled to terminate this Agreement                  by                  giving the Amerikal prior written notice of three (3)months. Neither                  of                  the parties shall be obliged to pay any compensation to the other                  party                  for loss of income or goodwill to the other party in such                  instance. |
|------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 12.4 | If                  Med-Eq should deem it necessary to recall the Product from the                  Territory,                  or in the event that recall of the Product is required by authorities,                  Med-Eq shall be entitled to terminate this Agreement by giving                  Amerikal                  three (3) months' written notice. Neither of the Parties shall                  be obliged                  to pay any compensation to the other party for loss of income or                  goodwill                  to the other party in such                  instance. |
|------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| **Art.                  1****3** | **Early                  Termination** |
|----------------------------------|----------------------------------------|

| 13.1 | Where                  one of the parties commits an essential breach of this Agreement                  the other                  party is entitled to terminate the Agreement, effective upon receipt                  of                  termination notice. |
|------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 1) | either                  party is adjudged bankrupt; suspends payment; or in any similar                  manner                  discontinues its business, |
|--------|----|-------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 2) | Amerikal                  violates Articles 5.2, 5.3, 5.4, 5.6, 6.1, 7.1, 8.3, 10.1 and                  10.2, |
|--------|----|----------------------------------------------------------------------------------------------------------------|

|   | 3) | Med-Eq                  violates Articles 3.2.2. |
|--------|----|--------------------------------------------------|

|   | 4) | If                  Amerikal fails to make any payment when                  due. |
|--------|----|-----------------------------------------------------------------------------------|

| 13.2 | In                  case one of the parties commits a breach in respect of its obligations                  under this Agreement which breach is not covered by Article 13.1,                  and                  where it does not make good such breach within thirty (30) days                  after                  being requested in writing to do so, the other party shall be entitled                  to                  terminate this Agreement, effective upon receipt of termination                  notice. |
|------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| **Art.                  1****4** | **Indemnity                  and Compensation** |
|----------------------------------|-------------------------------------------------|

| 14.1 | No                  claims for indemnity or compensation can be lodged by reason of                  the                  termination of the Agreement on any grounds, save where these claims                  are                  based on breach of Agreement by one of the                  Parties. |
|------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| **Art.                  1****5** | **Governing                  Law and Arbitration** |
|----------------------------------|----------------------------------------------------|

| 15.1 | The                  Agreement shall be deemed to have been entered into and to be construed                  and interpreted in accordance with the laws of Norway as applicable                  between residents of Norway. |
|------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 15.2 | Amerikal                  is obliged to accept changes in the Agreement made in order to                  comply with                  changes in mandatory law affecting this                  Agreement |
|------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 15.3 | Any                  dispute, controversy, or claim arising out of or in connection                  with the                  Agreement, including any question regarding its existence, validity,                  or                  termination, shall be finally resolved by arbitration under the                  Rules of                  The International Chamber of Commerce (excluding the conciliation                  Procedure) in force at the date of the request for arbitration,                  which                  Rules are deemed to be incorporated by reference into this                  clause. |
|------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | The                  tribunal shall consist of three                  arbitrators. |
|--------|------------------------------------------------------------------------------------|

|   | The                  place of arbitration shall be Oslo,                  Norway. |
|--------|-----------------------------------------------------------------------------------|

|   | The                  language of the arbitration shall be                  English. |
|--------|-------------------------------------------------------------------------------------|

----

| 15.4 | The                  governing language of this Agreement shall be English. Any translations                  made shall be for guidance only. |
|------|------------------------------------------------------------------------------------------------------------------------------------------------|

| 15.5 | If                  any provision of this Agreement or portion thereof shall to any                  extend be                  deemed invalid or unenforceable by any Court or authority having                  jurisdiction, the parties shall agree upon such adjustment of this                  Agreement as is necessary in order to secure as far as possible                  the vital                  interests of the Parties and the main objectives hereof at the                  time of                  signing this Agreement. Failing an understanding between the Parties                  on                  such adjustments they may be made by the arbitration tribunal in                  the                  course of any pursuant litigation. |
|------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 15.6 | Failure                  of a party to enforce one or more of the provisions of this Agreement                  or                  to exercise any option or other rights hereunder or to require                  at any time                  performance of any of the obligations hereof shall not be construed                  to be                  a waiver of such provisions by such party or to in any way affect                  the                  validity of this Agreement or such party ́s right thereafter to enforce                  each and every provision of this Agreement, nor to preclude such                  party                  from taking any other action at any time which it would legally                  be                  entitled to take. |
|------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 15.7 | The                  signatures of the parties set forth below is their acknowledgement                  that                  this Agreement sets forth their entire understanding and agreement                  and                  supersedes with effect from the commencement of this Agreement                  as provided                  in Article 14.1 any and all prior understandings, contracts or                  agreements                  between the Distributor and Med-Eq with respect to the subject                  matter of                  this Agreement. There are no representations or promises between                  the                  Parties hereto except as set forth herein. No provision of this                  Agreement                  may be waived, changed, terminated, modified or discharged, orally                  or                  otherwise, except by subsequent written agreement signed by the                  other                  party against whom such waiver, change, termination, modification                  or                  discharge is sought to be enforced. |
|------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| **Art.                  16** | **Assignability** |
|------------------------------|-------------------|

| 16.1 | This                  Agreement can be assigned by                  Med-Eq. |
|------|-----------------------------------------------------------------------------|

| 16.2 | This                  Agreement is non-assignable by Amerikal without the written consent                  of                  Med-Eq. |
|------|----------------------------------------------------------------------------------------------------------------------------------------|

| **Art.                  1****7** | **Pledge                  or Lien** |
|----------------------------------|-------------------------------------|

| 18.1 | Amerikal                  shall have no pledge or lien on the property of                  Med-Eq. |
|------|----------------------------------------------------------------------------------------------------|

| **Art.****18** | **Notices** |
|----------------|-------------|

| 18.1 | Any                  notice made in connection with this Agreement or performance thereunder                  shall be sent to the addresses specified below, or such other addresses                  as                  the parties may notify in writing to each other from time to time,                  by air                  courier or by telefax, followed immediately by a confirmation letter                  by                  airmail. |
|------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| If                    to Med-Eq:   | Med-Eq                    A/S                     |
|------------------------------------|---------------------------------------------------|
|                               | Farmannsveien                    18 - 22          |
|                               | N-3111                    Tønsberg           |
|                               | Norway                                            |
|                               |                                              |
|                               | Attn.:                    Managing Director       |
|                               | Fax:                    +47 33 35 90 69           |
|                               |                                              |
| If                    to Amerikal: | Amerikal                      Nutraceutical Corp. |
|                               | 17751                    Mitchell Avenue          |
|                               | Irvine,                    CA 92614               |
|                               | USA                                               |
|                               |                                              |
|                               | Attn.:                    President               |
|                               | Fax:                    +1.949.486.6688           |

**Med-Eq        A/S**

| By: | ____________________ |
|-----|----------------------|

**Amerikal**

| By: | ____________________ |
|-----|----------------------|

----

**List        of Appendixes**

| Appendix                1 | Product                  Description |
|---------------------------|--------------------------------------|

| Appendix                2 | Trademark,                  Design etc. |
|---------------------------|-----------------------------------------|

| Appendix                3 | Report                  Form |
|---------------------------|------------------------------|

----

**APPENDIX        1.1**

**PRODUCT        DESCRIPTION**

**Tthe        powder of fertilized and incubated hen eggs, YTE® - EU pat. No 0656781, US pat        No 5641517, for the use as an aphrodiziac/energy and in sports products.        **

**Med-Eq        shall supply the YTE® powder. **

**Registration        Category: Food or dietary supplement**

| Minimum                  quantities: | Year                  1 (1st 12 months) | 3000                  kilograms  |
|--------------------------------------|-----------------------------------------|----------------------------------|
|                                 | Year                  2 (2nd 12 months) | 12000                  kilograms |
|                                 | Year                  3 (3rd 12 months) | 12000                  kilograms |
|                                 | Year                  4 (4th 12 months) | 12000                  kilograms |
|                                 | Year                  5 (5th 12 months) | 12000                  kilograms |

| Storage                Conditions: | To                  be kept in unopened and sealed containers at 4 - 15 degrees C until                  confectioning. Opened containers are not to be stored. Avoid high                  humitity. |
|------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

**APPENDIX        2**

**TRADEMARK,        DESIGN, ETC.**

----

**APPENDIX        3**

**To:**

**From:**

**Date:**

| **Product:**                              | **Firm                  and Binding Orders** | **Forecast** |
|-------------------------------------------|----------------------------------------------|--------------|
| Monthly                  Past MonthReport | Month:                                       | Month:       | Month: | Month: | Month: | Month: |
| Stock                  begin-ning month   |                                         |         |   |   |   |   |   |
| Purchase                  from Med-Eq     |                                         |         |   |   |   |   |   |
| Sales                                     |                                         |         |   |   |   |   |   |
| Stock                  end month          |                                         |         |   |   |   |   |   |

**To        be sent by fax to +47 33 35 90 69 before the fifth working day of each        month.**

----

**Addendum        to**

**Sale        and Purchase Agreement of Sept 5 2005 **

**between**

**Med-Eq        AS**

**And**

**Amerikal        Nutraceutical Corp**

|   | 1. | Med-Eq                  hereby grants to Amerikal the exclusive USA rights to purchase                  the Product                  for formulation and production of finished products and shall refrain                  from                  accepting orders from third parties domiciled in the USA for as                  long as                  the Sale and Purchase Agreement is valid. |
|--------|----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 2. | This                  shall not limit Med-Eq from marketing finished products containing                  the                  Product in the USA or from accepting orders or otherwise dealing                  in                  finished products containing the Product. In case Med-Eq decides                  to enter                  into agreements for the USA market regarding the sale of its finished                  products containing the Product, Med-Eq shall offer to Amerikal                  the first                  right to confection and pack such products on its behalf on terms                  equal to                  those offered by any third party. |
|--------|----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 3. | Such                  exclusive right as is defined above shall remain in force under                  the                  lifetime of the Sale and Purchase Agreement, and is subject to                  minimum                  purchases as defined in Appendix 1.1 to this Agreement. |
|--------|----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 4. | This                  Addendum shall be interpreted as an integral part of the Sale and                  Purchase                  Agreement, and rules for interpretation, termination, resolving                  of                  conflicts as defined in the Sale and Purchase Agreement shall also                  apply                  to this Addendum. |
|--------|----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| Med-Eq                  AS                       | Amerikal                  Nutraceutical Corp.       |
|--------------------------------------------------|-----------------------------------------------------|
|                                             |                                                |
| ................................................ | ................................................... |

----